Clinical Trial Update: Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating different radiotherapy doses in combination with sintilimab for locally advanced esophageal squamous cell carcinoma; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Tyvyt (Sintilimab) (Sintilimab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING